期刊文献+

缺血性心肌病患者淋巴细胞PPAR-α与心室重构及心功能的相关性研究 被引量:6

PPAR-αexpression in lymphocytes of patients with ischemic cardiomyopathy and its corre- lation with cardiac functional
下载PDF
导出
摘要 目的:检测缺血性心肌病患者淋巴细胞过氧化物酶体增生激活型受体α(PPAR-α)的表达,并探讨其与心室重构及心功能状态的关系。方法:选择97例经冠状动脉造影、心脏彩超结合临床资料明确诊断的缺血性心肌病患者,根据纽约心功能分级:心功能Ⅰ级24例,Ⅱ级25例,Ⅲ级25例,Ⅳ级23例,选择冠脉造影正常、心功能正常的25例非冠心病患者作为对照组,分离周围血淋巴细胞,以ELISA法测定其淋巴细胞膜中的PPAR-α水平,以彩色多普勒超声心动图测定左室内径大小(LVD)、舒张末容积(EDV)及射血分数(EF),比较PPAR-α与左室重构和心功能的关系。结果:缺血性心肌病患者的PPAR-α表达水平较对照组显著下降[(41.65±8.92)pg/mL vs(55.32±6.89)pg/mL)];相关分析显示,缺血性心肌病患者PPAR-α的表达水平与左室内径、舒张末容积呈负相关﹙=-0.535,r=-0.672,P均<0.01﹚,与纽约心功能分级和EF值无明显相关。结论:缺血性心肌病患者外周血淋巴细胞中PPAR-α的表达下调,左室重构愈明显PPAR-α的表达下调越显著;PPAR-α的表达与纽约心功能分级和心脏射血分数无关,PPAR-α可能具有抗心肌重构的作用。 Objective. To investigate the level of PPAR-a in peripheral blood lymphocytes from pa- tients with ischemic cardiomyopathy (ICM), and the correlation between PPAR- and ventricular remode- ling g, cardiac function. Methods: A total of 97 cases of ischemic cardiomyopathy (ICM) were randomly di- vided into I -IV class by NYHA class. The class I had 24 cases, class 1I had 25 cases, class ]]] had 25 ca- ses and class Ivhad 23 cases. A total of 25 healthy people were enrolled as control group. PPAR-a expres- sion in lymphocytes was measured by ELISA, and left ventricular end (LVD), end-systolic volume (ESV) and left ventricular ejection fraction (LVEF) were determined by color Doppler echocardiography. Results: Expression of PPAR-a in peripheral lymphocytes of ICM group was lowered compared to that of control group [(41.65-t-8.92) pg/mL vs (55.32-t-6.89) pg/mL] PPAR-a expression has negative correlation
出处 《海南医学院学报》 CAS 2014年第2期184-187,共4页 Journal of Hainan Medical University
基金 海南省卫生厅科研资助项目(琼卫200760)~~
关键词 过氧化物酶体增生激活型受体a(PPAR-a) 缺血性心肌病 淋巴细胞 心室重构 心力衰竭 PPAR-αIschemic cardiomyopathy Lymphocytes Ventricular remodeling Heartfailure
  • 相关文献

参考文献10

  • 1Robinson E. Grieve DJ. Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease[J]. Pharmacology & Therapeutics. 2009. 122 (3): 246-263.
  • 2Vamecq J. Latruffe N. Medical significance of peroxisome proliferator-activated receptors [J]. V Lancet , 1999.354:141-148.
  • 3Lefebvre P. Chinetti G, Fruchart JC, et al. Sorting out the roles of PP AR-a in energy metabolism and vascular homeostasis[J]. J Clin Invest. 2006. 116 (3): 571- 580.
  • 4何喜民,马瑞莲,李天发,钟江华.过氧化物酶体增生激活型受体α(PPAR-α)在急性冠脉综合征(ACS)外周血淋巴细胞的表达状态及其与细胞TNF-α及hs-CRP的相关性研究[J].现代预防医学,2011,38(16):3278-3279. 被引量:1
  • 5Finck BN. The PP AR regulatory system in cardiac physiology and disease [J]. Cardiovascular Research, 2007,73:269-277.
  • 6Watanabe K,Fujii H,Takahashi T,et a1. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age dependent cardiac toxicitv [J]. J Bioi Chern, 2000,275:22293-22299.
  • 7Finek BN. Lehman JJ. Le one TC, et a1. The cardiac phenotype induced by PP AR alpha overexpression mimics that caused by diabetes mellitus[J]. J Clin Invest, 2002,109:121-130.
  • 8Young ME, Laws FA, Goodwin GW ,et a1. Reactivation of peroxisome prolifera for activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart[J]. J Bioi Chem,2001,276 :44390-44395.
  • 9Jamshidi Y, Montgomery HE, Hense HW , et a1. Peroxisome proliferators-activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension[J]. Circulation, 2002 , 105 : 950-955.
  • 10Goamez-Garr D,Herraz M,Gonzaalez-Rubi ML. Activation of peroxisome proliferator-activated receptor-a andg in auricular tissue from heart failure patients[J]. The European Journal of Heart Failure ,2006,8: 154-161.

二级参考文献9

同被引文献39

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部